More tools:Markets·Screener·Research·Chat

Sight Sciences, Inc. Common Stock (SGHT) Financial Statements

Sight Sciences, Inc. Common Stock
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG006BZHZD6
XNAS · usd
8.10▼ 0.25 (-2.99%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close8.35
Day's Range8.06 – 8.37
52-Week Range3.19 – 9.24
Volume166.6K
Avg Volume243.2K
Share Statistics
Shares Outstanding
Employees186
ExchangeXNAS
Listed2021-07-15
Share count as of July 31, 2026
Loading Income Statement…
Key questions about Sight Sciences, Inc. Common Stock (SGHT)
What is Sight Sciences, Inc. Common Stock's Market Cap?
Sight Sciences, Inc. Common Stock's Market Cap is $446.2M, based on as-reported figures from SEC (XBRL) filings.
What is Sight Sciences, Inc. Common Stock's Enterprise Value?
Sight Sciences, Inc. Common Stock's Enterprise Value is $417.4M, based on as-reported figures from SEC (XBRL) filings.
What is Sight Sciences, Inc. Common Stock's Price / Sales?
Sight Sciences, Inc. Common Stock's Price / Sales is 5.4×, based on as-reported figures from SEC (XBRL) filings.
What is Sight Sciences, Inc. Common Stock's EV / Revenue?
Sight Sciences, Inc. Common Stock's EV / Revenue is 5.0×, based on as-reported figures from SEC (XBRL) filings.
What is Sight Sciences, Inc. Common Stock's EV / EBITDA?
Sight Sciences, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Sight Sciences, Inc. Common Stock's Revenue (TTM)?
Sight Sciences, Inc. Common Stock's Revenue (TTM) is $83.4M, based on as-reported figures from SEC (XBRL) filings.
What is Sight Sciences, Inc. Common Stock's Net Income (TTM)?
Sight Sciences, Inc. Common Stock's Net Income (TTM) is -$29.8M, based on as-reported figures from SEC (XBRL) filings.
What is Sight Sciences, Inc. Common Stock's EBITDA?
Sight Sciences, Inc. Common Stock's EBITDA is -$27.5M, based on as-reported figures from SEC (XBRL) filings.
What is Sight Sciences, Inc. Common Stock's Diluted EPS (TTM)?
Sight Sciences, Inc. Common Stock's Diluted EPS (TTM) is -0.54, based on as-reported figures from SEC (XBRL) filings.
What is Sight Sciences, Inc. Common Stock's EBITDA Margin?
Sight Sciences, Inc. Common Stock's EBITDA Margin is -32.9%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth+19.5%+12.5%+6.9%-1.2%
Cost of goods sold
Gross profit
% of revenue91.4%86.2%87.3%86.4%
Operating expenses:
Research and development
Selling, general and administrative
Total operating expenses
% of revenue108.0%149.2%105.3%126.1%
Loss from operations
% of revenue-16.6%-63.0%-18.0%-39.7%
Investment income
Interest expense
Other income (expense), net
Loss before income taxes
Provision for income taxes
Net loss and comprehensive loss
% of revenue-19.0%-65.9%-20.4%-41.0%
Net loss per share attributable to common stockholders-basic
Net loss per share attributable to common stockholders-diluted